Westfield Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-253,491
| Closed | -$3.14M | – | 242 |
|
|
2022
Q4 | $3.14M | Sell |
253,491
-679,278
| -73% | -$8.42M | 0.02% | 197 |
|
|
2022
Q3 | $9.66M | Sell |
932,769
-1,383,359
| -60% | -$14.3M | 0.08% | 177 |
|
|
2022
Q2 | $26.7M | Sell |
2,316,128
-6,218,288
| -73% | -$71.7M | 0.21% | 149 |
|
|
2022
Q1 | $107M | Buy |
8,534,416
+388,742
| +5% | +$4.89M | 0.69% | 42 |
|
|
2021
Q4 | $95M | Sell |
8,145,674
-35,329
| -0.4% | -$412K | 0.56% | 57 |
|
|
2021
Q3 | $107M | Buy |
8,181,003
+1,922,130
| +31% | +$25.1M | 0.64% | 43 |
|
|
2021
Q2 | $80.6M | Buy |
6,258,873
+875,223
| +16% | +$11.3M | 0.48% | 74 |
|
|
2021
Q1 | $60.2M | Sell |
5,383,650
-3,104,392
| -37% | -$34.7M | 0.37% | 96 |
|
|
2020
Q4 | $96.7M | Buy |
8,488,042
+1,641,850
| +24% | +$18.7M | 0.57% | 59 |
|
|
2020
Q3 | $61.6M | Buy |
6,846,192
+1,504,988
| +28% | +$13.5M | 0.4% | 83 |
|
|
2020
Q2 | $55.1M | Buy |
5,341,204
+556,078
| +12% | +$5.74M | 0.38% | 90 |
|
|
2020
Q1 | $48.3M | Buy |
4,785,126
+2,348,030
| +96% | +$23.7M | 0.43% | 81 |
|
|
2019
Q4 | $32.4M | Sell |
2,437,096
-85,393
| -3% | -$1.14M | 0.23% | 133 |
|
|
2019
Q3 | $21.7M | Buy |
2,522,489
+129,715
| +5% | +$1.11M | 0.17% | 148 |
|
|
2019
Q2 | $26.2M | Buy |
2,392,774
+145,816
| +6% | +$1.6M | 0.2% | 152 |
|
|
2019
Q1 | $25.5M | Sell |
2,246,958
-111,048
| -5% | -$1.26M | 0.19% | 157 |
|
|
2018
Q4 | $20.5M | Buy |
2,358,006
+114,708
| +5% | +$995K | 0.17% | 155 |
|
|
2018
Q3 | $34.7M | Buy |
2,243,298
+580,974
| +35% | +$8.98M | 0.24% | 136 |
|
|
2018
Q2 | $26.6M | Buy |
+1,662,324
| New | +$26.6M | 0.2% | 156 |
|